Brenner T - Search Results

1

IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity.

Nizri E, Irony-Tur-Sinai M, Lavon I, Meshulam H, Amitai G, Brenner T. Nizri E, et al. Among authors: brenner t. Int Immunopharmacol. 2007 Sep;7(9):1129-39. doi: 10.1016/j.intimp.2007.03.009. Epub 2007 Apr 27. Int Immunopharmacol. 2007. PMID: 17630191

2

Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors.

Nizri E, Hamra-Amitay Y, Sicsic C, Lavon I, Brenner T. Nizri E, et al. Among authors: brenner t. Neuropharmacology. 2006 Apr;50(5):540-7. doi: 10.1016/j.neuropharm.2005.10.013. Epub 2005 Dec 5. Neuropharmacology. 2006. PMID: 16336980

3

Novel approaches to treatment of autoimmune neuroinflammation and lessons for drug development.

Nizri E, Irony-Tur-Sinai M, Grigoriadis N, Abramsky O, Amitai G, Brenner T. Nizri E, et al. Among authors: brenner t. Pharmacology. 2007;79(1):42-9. doi: 10.1159/000097628. Epub 2006 Nov 30. Pharmacology. 2007. PMID: 17139193 Review.

4

Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine.

Nizri E, Irony-Tur-Sinai M, Faranesh N, Lavon I, Lavi E, Weinstock M, Brenner T. Nizri E, et al. Among authors: brenner t. J Neuroimmunol. 2008 Oct 15;203(1):12-22. doi: 10.1016/j.jneuroim.2008.06.018. J Neuroimmunol. 2008. PMID: 18692909

5

IL2-caspase3 chimeric protein controls lymphocyte reactivity by targeted apoptosis, leading to amelioration of experimental autoimmune encephalomyelitis.

Irony-Tur-Sinai M, Lichtenstein M, Brenner T, Lorberboum-Galski H. Irony-Tur-Sinai M, et al. Among authors: brenner t. Int Immunopharmacol. 2009 Sep;9(10):1236-43. doi: 10.1016/j.intimp.2009.07.006. Epub 2009 Jul 22. Int Immunopharmacol. 2009. PMID: 19631295

6

Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.

Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T. Nizri E, et al. Among authors: brenner t. J Immunol. 2009 Nov 15;183(10):6681-8. doi: 10.4049/jimmunol.0902212. Epub 2009 Oct 21. J Immunol. 2009. PMID: 19846875

7

Bifunctional compounds eliciting both anti-inflammatory and cholinergic activity as potential drugs for neuroinflammatory impairments.

Nizri E, Adani R, Meshulam H, Amitai G, Brenner T. Nizri E, et al. Among authors: brenner t. Neurosci Lett. 2005 Mar 7;376(1):46-50. doi: 10.1016/j.neulet.2004.11.030. Epub 2004 Dec 8. Neurosci Lett. 2005. PMID: 15694272

8

A synthetic heparin-mimicking polyanionic compound inhibits central nervous system inflammation.

Irony-Tur-Sinai M, Vlodavsky I, Ben-Sasson SA, Pinto F, Sicsic C, Brenner T. Irony-Tur-Sinai M, et al. Among authors: brenner t. J Neurol Sci. 2003 Jan 15;206(1):49-57. doi: 10.1016/s0022-510x(02)00318-0. J Neurol Sci. 2003. PMID: 12480085

9

Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.

Irony-Tur-Sinai M, Grigoriadis N, Lourbopoulos A, Pinto-Maaravi F, Abramsky O, Brenner T. Irony-Tur-Sinai M, et al. Among authors: brenner t. Exp Neurol. 2006 Mar;198(1):136-44. doi: 10.1016/j.expneurol.2005.11.012. Epub 2006 Jan 19. Exp Neurol. 2006. PMID: 16423348

10

The role of cholinergic balance perturbation in neurological diseases.

Nizri E, Wirguin I, Brenner T. Nizri E, et al. Among authors: brenner t. Drug News Perspect. 2007 Sep;20(7):421-9. doi: 10.1358/dnp.2007.20.7.1149629. Drug News Perspect. 2007. PMID: 17992264 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

523 results

Search Page

Filters